Literature DB >> 27115504

Bioengineered Models of Solid Human Tumors for Cancer Research.

Alessandro Marturano-Kruik1,2, Aranzazu Villasante1,2, Gordana Vunjak-Novakovic3,4,5.   

Abstract

The lack of controllable in vitro models that can recapitulate the features of solid tumors such as Ewing's sarcoma limits our understanding of the tumor initiation and progression and impedes the development of new therapies. Cancer research still relies of the use of simple cell culture, tumor spheroids, and small animals. Tissue-engineered tumor models are now being grown in vitro to mimic the actual tumors in patients. Recently, we have established a new protocol for bioengineering the Ewing's sarcoma, by infusing tumor cell aggregates into the human bone engineered from the patient's mesenchymal stem cells. The bone niche allows crosstalk between the tumor cells, osteoblasts and supporting cells of the bone, extracellular matrix, and the tissue microenvironment. The bioreactor platform used in these experiments also allows the implementation of physiologically relevant mechanical signals. Here, we describe a method to build an in vitro model of Ewing's sarcoma that mimics the key properties of the native tumor and provides the tissue context and physical regulatory signals.

Entities:  

Keywords:  Bioreactor platform; Cancer research; Ewing’s sarcoma; Human sarcoma; Tumor model

Mesh:

Year:  2016        PMID: 27115504      PMCID: PMC4969218          DOI: 10.1007/7651_2016_353

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

1.  High drug attrition rates--where are we going wrong?

Authors:  Lisa Hutchinson; Rebecca Kirk
Journal:  Nat Rev Clin Oncol       Date:  2011-03-30       Impact factor: 66.675

2.  Mechanical compression drives cancer cells toward invasive phenotype.

Authors:  Janet M Tse; Gang Cheng; James A Tyrrell; Sarah A Wilcox-Adelman; Yves Boucher; Rakesh K Jain; Lance L Munn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-27       Impact factor: 11.205

Review 3.  Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression.

Authors:  Mina J Bissell; William C Hines
Journal:  Nat Med       Date:  2011-03       Impact factor: 53.440

4.  Bioengineered tumors.

Authors:  Aranzazu Villasante; Gordana Vunjak-Novakovic
Journal:  Bioengineered       Date:  2015-01-23       Impact factor: 3.269

Review 5.  Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models.

Authors:  Theodora Voskoglou-Nomikos; Joseph L Pater; Lesley Seymour
Journal:  Clin Cancer Res       Date:  2003-09-15       Impact factor: 12.531

6.  Can animal models of disease reliably inform human studies?

Authors:  H Bart van der Worp; David W Howells; Emily S Sena; Michelle J Porritt; Sarah Rewell; Victoria O'Collins; Malcolm R Macleod
Journal:  PLoS Med       Date:  2010-03-30       Impact factor: 11.069

7.  Mimicking biophysical stimuli within bone tumor microenvironment.

Authors:  A Marturano-Kruik; K Yeager; D Bach; A Villasante; E Cimetta; G Vunjak-Novakovic
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2015-08

8.  Bioengineered human tumor within a bone niche.

Authors:  Aranzazu Villasante; Alessandro Marturano-Kruik; Gordana Vunjak-Novakovic
Journal:  Biomaterials       Date:  2014-04-18       Impact factor: 12.479

Review 9.  The tumor microenvironment is a dominant force in multidrug resistance.

Authors:  Ana Luísa Correia; Mina J Bissell
Journal:  Drug Resist Updat       Date:  2012-02-13       Impact factor: 18.500

10.  In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model.

Authors:  Maureen E Lynch; Daniel Brooks; Sunish Mohanan; Min Joon Lee; Praveen Polamraju; Kelsey Dent; Lawrence J Bonassar; Marjolein C H van der Meulen; Claudia Fischbach
Journal:  J Bone Miner Res       Date:  2013-11       Impact factor: 6.741

View more
  6 in total

1.  Analysis of Keloid Response to 5-Fluorouracil Treatment and Long-Term Prevention of Keloid Recurrence.

Authors:  Ryan LaRanger; Anis Karimpour-Fard; Christopher Costa; David Mathes; Woodring E Wright; Tae Chong
Journal:  Plast Reconstr Surg       Date:  2019-02       Impact factor: 4.730

2.  Biomechanical regulation of drug sensitivity in an engineered model of human tumor.

Authors:  A Marturano-Kruik; A Villasante; K Yaeger; S R Ambati; A Chramiec; M T Raimondi; G Vunjak-Novakovic
Journal:  Biomaterials       Date:  2017-10-10       Impact factor: 12.479

Review 3.  Tissue engineered models of healthy and malignant human bone marrow.

Authors:  Alan Chramiec; Gordana Vunjak-Novakovic
Journal:  Adv Drug Deliv Rev       Date:  2019-04-17       Impact factor: 15.470

4.  How inclusive are cell lines in preclinical engineered cancer models?

Authors:  Shreya Raghavan
Journal:  Dis Model Mech       Date:  2022-06-01       Impact factor: 5.732

Review 5.  In vitro three-dimensional cell cultures for bone sarcomas.

Authors:  Javier Munoz-Garcia; Camille Jubelin; Aurélie Loussouarn; Matisse Goumard; Laurent Griscom; Axelle Renodon-Cornière; Marie-Françoise Heymann; Dominique Heymann
Journal:  J Bone Oncol       Date:  2021-07-06       Impact factor: 4.072

Review 6.  Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.

Authors:  Gianluca Colella; Flavio Fazioli; Michele Gallo; Annarosaria De Chiara; Gaetano Apice; Carlo Ruosi; Amelia Cimmino; Filomena de Nigris
Journal:  Int J Mol Sci       Date:  2018-02-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.